Background/Aims: Studies on the association between head circumference (HC) and height or weight have shown variable results. Methods: Using data from the Dutch nationwide survey performed in 1997 (n = 14,500), we calculated correlations for different ages, and fitted a regression model for the estimation of HC. HC versus height charts were created for different age groups. Data from children from other ethnic groups and children with various growth disorders were plotted on the charts and compared with reference data. Results: Correlations between HC and height or weight showed similar patterns: highest at birth, followed by a rapid decline to a stable level and a peak in adolescence. On charts containing the regression line ±2 standard deviations for subjects aged 0–2 months and 2 months to 21 years, Turkish and Moroccan children, as well as children with idiopathic short stature and small for gestational age, had a normal HC for height, whereas children with an insulin-like growth factor 1 receptor defect or Sotos syndrome showed trends towards a smaller or larger HC for height, respectively. Conclusion: HC correlates strongly with height and weight. The charts of HC for height may serve as an additional tool to interpret HC in short or tall children.

Keywords:
Head circumference, Cranial growth, Growth disorders, Sotos syndrome, IGF1R defect
1.
Fredriks AM, Van Buuren S, Burgmeijer RJ, et al: Continuing positive secular growth change in The Netherlands 1955–1997. Pediatr Res 2000;47:316–323.
2.
Fredriks AM, Van Buuren S, Jeurissen SE, et al: Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands. Eur J Pediatr 2003;162:788–793.
3.
Fredriks AM, Van Buuren S, Jeurissen SE, et al: Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. Acta Paediatr 2004;93:817–824.
4.
Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al: CDC growth charts: United States. Adv Data 2000;1–27.
5.
al Mazrou Y, al Amood MM, Khoja T, et al: Standardized national growth chart of 0–5-year-old Saudi children. J Trop Pediatr 2000;46:212–218.
6.
Walenkamp MJ, Wit JM: Genetic disorders in the growth hormone – insulin-like growth factor-I axis. Horm Res 2006;66:221–230.
7.
Walenkamp MJ, de Muinck Keizer-Schrama SM, de Mos M, et al: Successful long-term growth hormone therapy in a girl with haploinsufficiency of the IGF-I receptor due to a terminal 15q26.2–>qter deletion detected by multiplex ligation probe amplification. J Clin Endocrinol Metab 2008;93:2421–2425.
8.
Tatton-Brown K, Douglas J, Coleman K, et al: Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 2005;77:193–204.
9.
Buretic-Tomljanovic A, Ristic S, Brajenovic-Milic B, et al: Secular change in body height and cephalic index of Croatian medical students (University of Rijeka). Am J Phys Anthropol 2004;123:91–96.
10.
Chiba M, Terazawa K: Estimation of stature from somatometry of skull. Forensic Sci Int 1998;97:87–92.
11.
Dine MS, Gartside PS, Glueck CJ, et al: Relationship of head circumference to length in the first 400 days of life: a mnemonic. Pediatrics 1981;67:506–507.
12.
Illingworth RS, Eid EE: The head circumference in infants and other measurements to which it may be related. Acta Paediatr Scand 1971;60:333–337.
13.
Krishan K, Kumar R: Determination of stature from cephalo-facial dimensions in a North Indian population. Leg Med (Tokyo) 2007;9:128–133.
14.
Martins AM, Lyons JK: Correlation of occipitofrontal circumference and crown-rump length from birth to 15 months. Clin Dysmorphol 1994;3:157–159.
15.
Saunders CL, Lejarraga H, del Pino M: Assessment of head size adjusted for height: an anthropometric tool for clinical use based on Argentinian data. Ann Hum Biol 2006;33:415–423.
16.
Yang SS, Chen YC, Brough AJ, et al: Correlation of head circumference and crown-rump length in newborn infants. A potential indicator of congenital maldevelopment. Biol Neonate 1975;27:308–317.
17.
Prader A, Largo RH, Molinari L, et al: Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 1989;52:1–125.
18.
Wit JM, Finken MJ, Rijken M, et al: Confusion around the definition of small for gestational age. Pediatr Endocrinol Rev 2005;3:52–53.
19.
Wit JM, Clayton PE, Rogol AD, et al: Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 2008;18:89–110.
20.
Abuzzahab MJ, Schneider A, Goddard A, et al: IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003;349:2211–2222.
21.
Okubo Y, Siddle K, Firth H, et al: Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. J Clin Endocrinol Metab 2003;88:5981–5988.
22.
Pinson L, Perrin A, Plouzennec C, et al: Detection of an unexpected subtelomeric 15q26.2–>qter deletion in a little girl: clinical and cytogenetic studies. Am J Med Genet A 2005;138:160–165.
23.
Poot M, Eleveld MJ, van ‘t Slot R, et al: Proportional growth failure and oculocutaneous albinism in a girl with a 6.87 Mb deletion of region 15q26.2–>qter. Eur J Med Genet 2007;50:432–440.
24.
Roback EW, Barakat AJ, Dev VG, et al: An infant with deletion of the distal long arm of chromosome 15 (q26.1–>qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet 1991;38:74–79.
25.
Rujirabanjerd S, Suwannarat W, Sripo T, et al: De novo subtelomeric deletion of 15q associated with satellite translocation in a child with developmental delay and severe growth retardation. Am J Med Genet A 2007;143:271–276.
26.
Tonnies H, Schulze I, Hennies H, et al: De novo terminal deletion of chromosome 15q26.1 characterised by comparative genomic hybridisation and FISH with locus specific probes. J Med Genet 2001;38:617–621.
27.
Ester W, de Wit C, Wit JM, et al: Two new short SGA children with IGF1-R haploinsufficiency illustrate the heterogeneous phenotype of IGF1-R mutations. Horm Res 2007;68:S208.
28.
Walenkamp MJ, van der Kamp HJ, Pereira AM, et al: A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab 2006;91:3062–3070.
29.
de Boer L, Kant SG, Karperien M, et al: Genotype-phenotype correlation in patients suspected of having Sotos syndrome. Horm Res 2004;62:197–207.
30.
Cole TJ, Green PJ: Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992;11:1305–1319.
31.
Niklasson A, Ericson A, Fryer JG, et al: An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand 1991;80:756–762.
32.
Kant SG, Kriek M, Walenkamp MJ, et al: Tall stature and duplication of the insulin-like growth factor I receptor gene. Eur J Med Genet 2007;50:1–10.
33.
Karlberg J: On the modelling of human growth. Stat Med 1987;6:185–192.
34.
Largo RH: Developmental risks and outcome of very low birth weight infants. J Perinat Med 1991;(suppl 1):327–332.
35.
Zachmann M, Fernandez F, Tassinari D, et al: Anthropometric measurements in patients with growth hormone deficiency before treatment with human growth hormone. Eur J Pediatr 1980;133:277–282.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.